NDC 0121-1796

Atovaquone

Atovaquone

Atovaquone is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Pai Holdings, Llc. The primary component is Atovaquone.

Product ID0121-1796_0d67fa4c-b36a-4d81-8e7d-a661db92df22
NDC0121-1796
Product TypeHuman Prescription Drug
Proprietary NameAtovaquone
Generic NameAtovaquone
Dosage FormSuspension
Route of AdministrationORAL
Marketing Start Date2018-10-11
Marketing CategoryANDA /
Application NumberANDA210692
Labeler NamePAI Holdings, LLC
Substance NameATOVAQUONE
Active Ingredient Strength1500 mg/10mL
Pharm ClassesAntimalarial [EPC], Antiprotozoal [EPC]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 0121-1796-20

2 TRAY in 1 CASE (0121-1796-20) > 10 PACKAGE in 1 TRAY > 10 mL in 1 PACKAGE (0121-1796-10)
Marketing Start Date2021-12-16
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Atovaquone" or generic name "Atovaquone"

NDCBrand NameGeneric Name
0121-0888AtovaquoneAtovaquone
0121-0898AtovaquoneAtovaquone
0121-1796AtovaquoneAtovaquone
0904-7064AtovaquoneAtovaquone
16714-900atovaquoneatovaquone
31722-629AtovaquoneAtovaquone
50268-086AtovaquoneAtovaquone
51407-642AtovaquoneAtovaquone
60687-534AtovaquoneAtovaquone
65162-693ATOVAQUONEATOVAQUONE
66689-062AtovaquoneAtovaquone
66993-062Atovaquoneatovaquone
68180-282AtovaquoneAtovaquone
68462-421atovaquoneatovaquone
70166-488AtovaquoneAtovaquone
10702-223Atovaquone Oral SuspensionAtovaquone
0173-0547MEPRONatovaquone
0173-0665MEPRONatovaquone
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.